Correlation Between Biotechnology Ultrasector and Mid Capitalization

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biotechnology Ultrasector and Mid Capitalization at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotechnology Ultrasector and Mid Capitalization into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biotechnology Ultrasector Profund and Mid Capitalization Portfolio, you can compare the effects of market volatilities on Biotechnology Ultrasector and Mid Capitalization and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotechnology Ultrasector with a short position of Mid Capitalization. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotechnology Ultrasector and Mid Capitalization.

Diversification Opportunities for Biotechnology Ultrasector and Mid Capitalization

-0.1
  Correlation Coefficient

Good diversification

The 3 months correlation between Biotechnology and Mid is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Biotechnology Ultrasector Prof and Mid Capitalization Portfolio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mid Capitalization and Biotechnology Ultrasector is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotechnology Ultrasector Profund are associated (or correlated) with Mid Capitalization. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mid Capitalization has no effect on the direction of Biotechnology Ultrasector i.e., Biotechnology Ultrasector and Mid Capitalization go up and down completely randomly.

Pair Corralation between Biotechnology Ultrasector and Mid Capitalization

Assuming the 90 days horizon Biotechnology Ultrasector Profund is expected to generate 1.86 times more return on investment than Mid Capitalization. However, Biotechnology Ultrasector is 1.86 times more volatile than Mid Capitalization Portfolio. It trades about 0.02 of its potential returns per unit of risk. Mid Capitalization Portfolio is currently generating about 0.02 per unit of risk. If you would invest  6,115  in Biotechnology Ultrasector Profund on September 12, 2024 and sell it today you would earn a total of  500.00  from holding Biotechnology Ultrasector Profund or generate 8.18% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy99.8%
ValuesDaily Returns

Biotechnology Ultrasector Prof  vs.  Mid Capitalization Portfolio

 Performance 
       Timeline  
Biotechnology Ultrasector 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biotechnology Ultrasector Profund has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong forward indicators, Biotechnology Ultrasector is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Mid Capitalization 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mid Capitalization Portfolio has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong fundamental indicators, Mid Capitalization is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Biotechnology Ultrasector and Mid Capitalization Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biotechnology Ultrasector and Mid Capitalization

The main advantage of trading using opposite Biotechnology Ultrasector and Mid Capitalization positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotechnology Ultrasector position performs unexpectedly, Mid Capitalization can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mid Capitalization will offset losses from the drop in Mid Capitalization's long position.
The idea behind Biotechnology Ultrasector Profund and Mid Capitalization Portfolio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments